Markus Joachim Seibel

Markus Joachim Seibel

Auto-generated profile, based on publicly available information

Markus Joachim Seibel

Bone Research Program, ANZAC Research Institute, The University of Sydney, Australia

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
DGDanijela Gnjidic
Danijela Gnjidic
SHSarah N. Hilmer
Sarah N. Hilmer
FBFiona M. Blyth
Fiona M. Blyth
VNVasi Naganathan
Vasi Naganathan
LWLouise Waite
Louise Waite
DCDavid G. Le Couteur
David G. Le Couteur

1 December 2000 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
PDP. D. Delmas
P. D. Delmas
RER. Eastell
R. Eastell
PGP. Garnero
P. Garnero
MSM. J. Seibel
M. J. Seibel
JSJan Josef Stepan
Jan Josef Stepan

4 November 2010 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
NHNoran Naqiah Hairi
Noran Naqiah Hairi
RCRobert G. Cumming
Robert G. Cumming
VNVasi Naganathan
Vasi Naganathan
DHDavid J. Handelsman
David J. Handelsman
DCDavid G. Le Couteur
David G. Le Couteur
PSPhilip N. Sambrook
Philip N. Sambrook

25 July 2012 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
KGK. Ganda
K. Ganda
MPM. Puech
M. Puech
JCJ. S. Chen
J. S. Chen
RSR. Speerin
R. Speerin
JBJ. Bleasel
J. Bleasel
MSM. J. Seibel
M. J. Seibel

18 June 2012 in Medical Journal of Australia
Verified
Journal Article
Closed access
CNCaryl Nowson
Caryl Nowson
JMJohn McGrath
John McGrath
PEPeter R Ebeling
Peter R Ebeling
AHAnjali Haikerwal
Anjali Haikerwal
RDRobin Daly
Robin Daly
RMRebecca Sara Mason
Rebecca Sara Mason
To the Editor: Our scepticism about the value of many of the burgeoning number of clinical guidelines is reinforced by the position statement on vitamin D and health for adults.1 It was surprising not to find an explicit statement that there is Level I evidence that vitamin D monotherapy does not prevent falls2 or fractures3 or reduce mortality.4 Instead, Nowson and colleagues conclude that “there ...

14 January 2008 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
CMChristian Meier
Christian Meier
TNTuan V. Nguyen
Tuan V. Nguyen
DHDavid J. Handelsman
David J. Handelsman
CSChristian Schindler
Christian Schindler
MKMark M. Kushnir
Mark M. Kushnir
MSMarkus J. Seibel
Markus J. Seibel
One-third of all osteoporotic fractures occur in men. After the age of 60 years, the residual lifetime risk of hip or vertebral fracture in men is similar to that of prostate cancer.1,2 Moreover, in men, a prior osteoporotic fracture increases the risk of subsequent fracture by 3- to 4-fold to at least that of a woman of the same age with a fracture.3 Preventing the first such fracture may have major public health implications. Thus, understanding the determinants of fracture risk in men may reduce the burden of disease through facilitating better prevention strategies.